Global Cancer Targeted Small Molecule Therapy market growth is projected to reach  US$ 65370 million in 2025 to US$ 113610 million in 2031; it is expected to grow at a CAGR of 9.6% from 2025 to 2031.

Global Cancer Targeted Small Molecule Therapy Market Trends and Analysis 2025-31

The global Cancer Targeted Small Molecule Therapy market size is predicted to grow from US$ 65370 million in 2025 to US$ 113610 million in 2031; it is expected to grow at a CAGR of 9.6% from 2025 to 2031. Targeted therapy isa type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. LPI (LP Information) newest research report, the Cancer Targeted Small Molecule Therapy Industry Forecast looks at past sales and reviews total world Cancer Targeted Small Molecule Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Cancer Targeted Small Molecule Therapy sales for 2025 through 2031. With Cancer Targeted Small Molecule Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Targeted Small Molecule Therapy industry. This Insight Report provides a comprehensive analysis of the global Cancer Targeted Small Molecule Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cancer Targeted Small Molecule Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Cancer Targeted Small Molecule Therapy market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Targeted Small Molecule Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Targeted Small Molecule Therapy. This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Targeted Small Molecule Therapy market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Sorafenib &nbsp;&nbsp;&nbsp; Lenvatinib &nbsp;&nbsp;&nbsp; Regorafenib &nbsp;&nbsp;&nbsp; Osimertinib &nbsp;&nbsp;&nbsp; Anlotinib &nbsp;&nbsp;&nbsp; Alectinib &nbsp;&nbsp;&nbsp; Other Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Retail Pharmacy &nbsp;&nbsp;&nbsp; Other This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Bayer &nbsp;&nbsp;&nbsp; Eisai &nbsp;&nbsp;&nbsp; Zelgen &nbsp;&nbsp;&nbsp; Cipla &nbsp;&nbsp;&nbsp; Natco Pharma &nbsp;&nbsp;&nbsp; AstraZeneca &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Roche &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; BEACON Pharma &nbsp;&nbsp;&nbsp; Jiangxi Shanxiang &nbsp;&nbsp;&nbsp; Yao Pharma &nbsp;&nbsp;&nbsp; CSPC &nbsp;&nbsp;&nbsp; CHIATAI Tianqing &nbsp;&nbsp;&nbsp; Simcere

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Cancer Targeted Small Molecule Therapy Market Size (2020-2031) &nbsp;2.1.2 Cancer Targeted Small Molecule Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Cancer Targeted Small Molecule Therapy by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Cancer Targeted Small Molecule Therapy Segment by Type &nbsp;2.2.1 Sorafenib &nbsp;2.2.2 Lenvatinib &nbsp;2.2.3 Regorafenib &nbsp;2.2.4 Osimertinib &nbsp;2.2.5 Anlotinib &nbsp;2.2.6 Alectinib &nbsp;2.2.7 Other &nbsp;2.3 Cancer Targeted Small Molecule Therapy Market Size by Type &nbsp;2.3.1 Cancer Targeted Small Molecule Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Cancer Targeted Small Molecule Therapy Market Size Market Share by Type (2020-2025) &nbsp;2.4 Cancer Targeted Small Molecule Therapy Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Retail Pharmacy &nbsp;2.4.3 Other &nbsp;2.5 Cancer Targeted Small Molecule Therapy Market Size by Application &nbsp;2.5.1 Cancer Targeted Small Molecule Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Cancer Targeted Small Molecule Therapy Market Size Market Share by Application (2020-2025) 3 Cancer Targeted Small Molecule Therapy Market Size by Player &nbsp;3.1 Cancer Targeted Small Molecule Therapy Market Size Market Share by Player &nbsp;3.1.1 Global Cancer Targeted Small Molecule Therapy Revenue by Player (2020-2025) &nbsp;3.1.2 Global Cancer Targeted Small Molecule Therapy Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Cancer Targeted Small Molecule Therapy Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Cancer Targeted Small Molecule Therapy by Region &nbsp;4.1 Cancer Targeted Small Molecule Therapy Market Size by Region (2020-2025) &nbsp;4.2 Global Cancer Targeted Small Molecule Therapy Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Cancer Targeted Small Molecule Therapy Market Size Growth (2020-2025) &nbsp;4.4 APAC Cancer Targeted Small Molecule Therapy Market Size Growth (2020-2025) &nbsp;4.5 Europe Cancer Targeted Small Molecule Therapy Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Cancer Targeted Small Molecule Therapy Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Cancer Targeted Small Molecule Therapy Market Size by Country (2020-2025) &nbsp;5.2 Americas Cancer Targeted Small Molecule Therapy Market Size by Type (2020-2025) &nbsp;5.3 Americas Cancer Targeted Small Molecule Therapy Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Cancer Targeted Small Molecule Therapy Market Size by Region (2020-2025) &nbsp;6.2 APAC Cancer Targeted Small Molecule Therapy Market Size by Type (2020-2025) &nbsp;6.3 APAC Cancer Targeted Small Molecule Therapy Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Cancer Targeted Small Molecule Therapy Market Size by Country (2020-2025) &nbsp;7.2 Europe Cancer Targeted Small Molecule Therapy Market Size by Type (2020-2025) &nbsp;7.3 Europe Cancer Targeted Small Molecule Therapy Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Cancer Targeted Small Molecule Therapy by Region (2020-2025) &nbsp;8.2 Middle East & Africa Cancer Targeted Small Molecule Therapy Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Cancer Targeted Small Molecule Therapy Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Cancer Targeted Small Molecule Therapy Market Forecast &nbsp;10.1 Global Cancer Targeted Small Molecule Therapy Forecast by Region (2026-2031) &nbsp;10.1.1 Global Cancer Targeted Small Molecule Therapy Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.1.3 APAC Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.1.4 Europe Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.1.5 Middle East & Africa Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.2 Americas Cancer Targeted Small Molecule Therapy Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.2.2 Canada Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.2.3 Mexico Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.2.4 Brazil Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.3 APAC Cancer Targeted Small Molecule Therapy Forecast by Region (2026-2031) &nbsp;10.3.1 China Cancer Targeted Small Molecule Therapy Market Forecast &nbsp;10.3.2 Japan Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.3.3 Korea Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.3.4 Southeast Asia Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.3.5 India Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.3.6 Australia Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.4 Europe Cancer Targeted Small Molecule Therapy Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.4.2 France Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.4.3 UK Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.4.4 Italy Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.4.5 Russia Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.5 Middle East & Africa Cancer Targeted Small Molecule Therapy Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.5.2 South Africa Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.5.3 Israel Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.5.4 Turkey Market Cancer Targeted Small Molecule Therapy Forecast &nbsp;10.6 Global Cancer Targeted Small Molecule Therapy Forecast by Type (2026-2031) &nbsp;10.7 Global Cancer Targeted Small Molecule Therapy Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Cancer Targeted Small Molecule Therapy Forecast 11 Key Players Analysis &nbsp;11.1 Bayer &nbsp;11.1.1 Bayer Company Information &nbsp;11.1.2 Bayer Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.1.3 Bayer Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Bayer Main Business Overview &nbsp;11.1.5 Bayer Latest Developments &nbsp;11.2 Eisai &nbsp;11.2.1 Eisai Company Information &nbsp;11.2.2 Eisai Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.2.3 Eisai Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Eisai Main Business Overview &nbsp;11.2.5 Eisai Latest Developments &nbsp;11.3 Zelgen &nbsp;11.3.1 Zelgen Company Information &nbsp;11.3.2 Zelgen Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.3.3 Zelgen Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Zelgen Main Business Overview &nbsp;11.3.5 Zelgen Latest Developments &nbsp;11.4 Cipla &nbsp;11.4.1 Cipla Company Information &nbsp;11.4.2 Cipla Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.4.3 Cipla Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Cipla Main Business Overview &nbsp;11.4.5 Cipla Latest Developments &nbsp;11.5 Natco Pharma &nbsp;11.5.1 Natco Pharma Company Information &nbsp;11.5.2 Natco Pharma Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.5.3 Natco Pharma Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Natco Pharma Main Business Overview &nbsp;11.5.5 Natco Pharma Latest Developments &nbsp;11.6 AstraZeneca &nbsp;11.6.1 AstraZeneca Company Information &nbsp;11.6.2 AstraZeneca Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.6.3 AstraZeneca Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 AstraZeneca Main Business Overview &nbsp;11.6.5 AstraZeneca Latest Developments &nbsp;11.7 Novartis &nbsp;11.7.1 Novartis Company Information &nbsp;11.7.2 Novartis Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.7.3 Novartis Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Novartis Main Business Overview &nbsp;11.7.5 Novartis Latest Developments &nbsp;11.8 Roche &nbsp;11.8.1 Roche Company Information &nbsp;11.8.2 Roche Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.8.3 Roche Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Roche Main Business Overview &nbsp;11.8.5 Roche Latest Developments &nbsp;11.9 Bristol-Myers Squibb &nbsp;11.9.1 Bristol-Myers Squibb Company Information &nbsp;11.9.2 Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.9.3 Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Bristol-Myers Squibb Main Business Overview &nbsp;11.9.5 Bristol-Myers Squibb Latest Developments &nbsp;11.10 Pfizer &nbsp;11.10.1 Pfizer Company Information &nbsp;11.10.2 Pfizer Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.10.3 Pfizer Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Pfizer Main Business Overview &nbsp;11.10.5 Pfizer Latest Developments &nbsp;11.11 BEACON Pharma &nbsp;11.11.1 BEACON Pharma Company Information &nbsp;11.11.2 BEACON Pharma Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.11.3 BEACON Pharma Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 BEACON Pharma Main Business Overview &nbsp;11.11.5 BEACON Pharma Latest Developments &nbsp;11.12 Jiangxi Shanxiang &nbsp;11.12.1 Jiangxi Shanxiang Company Information &nbsp;11.12.2 Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.12.3 Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 Jiangxi Shanxiang Main Business Overview &nbsp;11.12.5 Jiangxi Shanxiang Latest Developments &nbsp;11.13 Yao Pharma &nbsp;11.13.1 Yao Pharma Company Information &nbsp;11.13.2 Yao Pharma Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.13.3 Yao Pharma Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 Yao Pharma Main Business Overview &nbsp;11.13.5 Yao Pharma Latest Developments &nbsp;11.14 CSPC &nbsp;11.14.1 CSPC Company Information &nbsp;11.14.2 CSPC Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.14.3 CSPC Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.14.4 CSPC Main Business Overview &nbsp;11.14.5 CSPC Latest Developments &nbsp;11.15 CHIATAI Tianqing &nbsp;11.15.1 CHIATAI Tianqing Company Information &nbsp;11.15.2 CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.15.3 CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.15.4 CHIATAI Tianqing Main Business Overview &nbsp;11.15.5 CHIATAI Tianqing Latest Developments &nbsp;11.16 Simcere &nbsp;11.16.1 Simcere Company Information &nbsp;11.16.2 Simcere Cancer Targeted Small Molecule Therapy Product Offered &nbsp;11.16.3 Simcere Cancer Targeted Small Molecule Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.16.4 Simcere Main Business Overview &nbsp;11.16.5 Simcere Latest Developments 12 Research Findings and Conclusion

Report	Global Cancer Targeted Small Molecule Therapy Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI13697

Buyer Information

Order Summary